Skip Navigation


Brain Advance Access originally published online on September 26, 2007
Brain 2008 131(1):e87; doi:10.1093/brain/awm221
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
131/1/e87    most recent
awm221v3
awm221v2
awm221v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Thannickal, T. C.
Right arrow Articles by Siegel, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thannickal, T. C.
Right arrow Articles by Siegel, J. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Hypocretin (orexin) and melanin concentrating hormone loss and the symptoms of Parkinson's disease

Thomas C. Thannickal, Yuan-Yang Lai and Jerome M. Siegel

Department of Psychiatry, University of California at Los Angeles, Los Angeles, CA 90095, Neurobiology Research (151A3), Veterans Administration Greater Los Angeles Healthcare System, North Hills, CA 91343 and Brain Research Institute, University of California at Los Angeles, Los Angeles, CA 90095

Correspondence to: Jerome M. Siegel, PhD, UCLA/VAGLAHS – Sepulveda, Neurobiology Research (151A3), 16111 Plummer Street, North Hills, CA 91343, USA E-mail: jsiegel@ucla.edu

Key Words: Parkinson; narcolepsy; sleep; hypocretin; orexin; melanin concentrating hormone

The first 10% of the full text of this article appears below.

We reported that Parkinson's disease (PD) patients have a substantial loss of hypocretin (Hcrt) cells (Thannickal et al., 2007Go). As two of the authors of the letter to which we are responding have emphasized in their prior publication (Baumann et al., 2005Go), and as other groups have reported, the sleep disturbances associated with PD are a major complaint in a large proportion of these patients (Arnulf et al., 2000Go; Frucht et al., 2000Go; Arnulf et al., 2002Go; Frucht, 2002Go; . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 BrainHome page
Y. Compta, J. Santamaria, L. Ratti, E. Tolosa, A. Iranzo, E. Munoz, F. Valldeoriola, R. Casamitjana, J. Rios, and M. J. Marti
Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia
Brain, October 25, 2009; (2009) awp263v1.
[Abstract] [Full Text] [PDF]